Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement and Interim Management Statement

9 May 2012 11:00

RNS Number : 9646C
Savills PLC
09 May 2012
 



 

 

9 May 2012

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 20 Grosvenor Hill, Berkeley Square, London W1K 3HQ and provides the following Interim Management Statement (IMS) for the period to 9 May 2012.

 

During the first four months of the year Savills has traded overall in line with our expectations. The first quarter saw the anticipated slower markets in Asia, a robust performance from the UK Residential business and continued strengthening of our US pipeline. The UK Commercial business performed well, particularly in central London. The markets of Continental Europe continue to be weak and, against the backdrop of increasing political and economic uncertainty, transactions are taking longer to complete or being put on hold.

 

London's attractions as an investment location remain firmly established. Fiscal changes announced in this year's budget had a short term effect on transaction volumes in the Prime Residential market in London, but they appear to have substantially recovered. Continued political and economic turbulence in many parts of the world has maintained investor interest in London's prime residential property. Outside London we have seen an increase in the volume of activity in the UK Country market both in terms of new stock and applicants. In the residential markets of Greater China and Singapore transaction volumes have been subdued, as anticipated, at this stage in the year.

 

The acquisition of Gresham Down LLP in January has supported our Commercial transaction business in Prime Central London, which has out-performed our expectations during the period and reduced the impact of relative weakness in commercial markets outside London. In Greater China, particularly in the established markets of Shanghai and Beijing, our commercial transaction advisory pipelines have continued to build strongly, supported by the attention of investors and developers progressively turning to office investment from residential assets. It is too early to call a recovery in Hong Kong, but the banking market has recommenced lending on commercial investment, albeit at relatively modest levels, and this bodes well for our performance in the second half of the year.

 

Globally, our Consultancy and Property Management businesses have continued to deliver strong revenue and profit growth and Cordea Savills, the Group's fund management business, has performed as anticipated. The Group continues to manage a strong balance sheet.

 

We continue to anticipate that our financial performance in 2012 will be weighted towards the second half of the year.

 

For further information, contact:

 

Savills 020 7409 8844

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGGKLLFGZZG
Date   Source Headline
11th Nov 20213:19 pmRNSDirector/PDMR Shareholding
11th Nov 20219:16 amRNSDirector/PDMR Shareholding
9th Nov 20217:00 amRNSTrading update
1st Nov 202110:00 amRNSTotal Voting Rights
15th Oct 20212:28 pmRNSHolding(s) in Company
12th Oct 20213:41 pmRNSDirector/PDMR Shareholding
6th Oct 20214:19 pmRNSSIMON HOPE STEPS DOWN FROM SAVILLS EXECUTIVE BOARD
1st Oct 202110:00 amRNSTotal Voting Rights
21st Sep 20211:00 pmRNSDirector/PDMR Shareholding
13th Sep 20211:00 pmRNSDirector/PDMR Shareholding
8th Sep 202110:00 amRNSAdditional Listing
1st Sep 202110:00 amRNSTotal Voting Rights
16th Aug 202111:40 amRNSDirector/PDMR Shareholding
16th Aug 202111:30 amRNSBlock listing Interim Review
11th Aug 20213:27 pmRNSDirector/PDMR Shareholding
5th Aug 20217:00 amRNSHalf-year Report
2nd Aug 202111:23 amRNSHolding(s) in Company
2nd Aug 202111:23 amRNSTotal Voting Rights
21st Jul 202110:00 amRNSBlock listing Interim Review
1st Jul 202110:00 amRNSTotal Voting Rights
30th Jun 20214:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20212:42 pmRNSDirector/PDMR Shareholding
18th Jun 202111:12 amRNSDirector/PDMR Shareholding
14th Jun 20211:36 pmRNSDirector/PDMR Shareholding
11th Jun 202112:47 pmRNSDirector/PDMR Shareholding
10th Jun 20214:56 pmRNSDirector/PDMR Shareholding
2nd Jun 20212:49 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSTotal Voting Rights
28th May 20211:23 pmRNSCompletion of Acquisition
27th May 20218:04 amRNSSavills IM & Samsung Life Investment Alliance
20th May 202110:45 amRNSOption to acquire outstanding 75% of DRC exercised
12th May 202112:45 pmRNSResult of AGM
12th May 202111:51 amRNSAGM Statement
11th May 202111:00 amRNSDirector/PDMR Shareholding
13th Apr 20211:34 pmRNSDirector/PDMR Shareholding
6th Apr 20213:32 pmRNSAnnual Report and AGM Notice
1st Apr 20213:00 pmRNSTotal Voting Rights
22nd Mar 20219:20 amRNSHolding(s) in Company
11th Mar 20214:45 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSFinal Results
10th Mar 20216:10 pmRNSHolding(s) in Company
1st Mar 202110:07 amRNSTotal Voting Rights
15th Feb 202112:10 pmRNSBlock listing Interim Review
15th Feb 20219:15 amRNSHolding(s) in Company
11th Feb 20214:37 pmRNSHolding(s) in Company
11th Feb 20214:37 pmRNSDirector/PDMR Shareholding
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20219:26 amRNSHolding(s) in Company
21st Jan 20213:37 pmRNSBlock listing Interim Review
18th Jan 20214:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.